Shani Alexander

Journalist at BioWorld

Journalist at BioWorld Science

Featured in: Favicon

bioworld.com Favicon

law360.com

Articles

Aiatella secures €2M for AI-based cardiovascular imaging tech

3 weeks ago | bioworld.com | Shani Alexander

Aiatella secures €2M for AI-based cardiovascular imaging techAiatella Oy secured €2 million (US$2.28 million) in funding for its AI-powered cardiovascular imaging technology. The funds will be used to conduct clinical trials and develop the company’s ultrasound-based preventative screening tool, which detects and quantifies carotid artery narrowing in minutes. BioWorld MedTech Financings Artificial intelligence Cardiovascular Europe
Menstrual blood-based device detects disease biomarkers

3 weeks ago | bioworld.com | Shani Alexander

Menstrual blood-based device detects disease biomarkersResearchers at ETH Zürich developed Menstruai, a device that detects in menstruation blood biomarkers associated with certain diseases. Menstruai uses a sensor built into a sanitary pad and changes color if certain biomarkers are present. The first of its kind technology has the potential to enable the early detection of diseases and transform women’s health care. BioWorld MedTech Clinical Women's health Europe
Paradromics joins BCI in-human race

3 weeks ago | bioworld.com | Shani Alexander

Paradromics joins BCI in-human raceParadromics Inc. became the latest company developing a brain-computer interface (BCI) system to implant its technology, Connexus, into a human. The device was safely implanted, it recorded electrical brain signals and was removed intact in less than 20 minutes. Paradromics hopes to begin clinical trials later this year. BioWorld MedTech Clinical Neurology/psychiatric U.S.
Amber Vcfix spinal system shows promising data

3 weeks ago | bioworld.com | Shani Alexander

Amber Vcfix spinal system shows promising dataAmber Implants BV reported no device-related adverse events were seen in any of the patients fitted with its Vcfix spinal system, which treats vertebral compression fractures, at one-year. Data from the first-in-human trial of the device also showed patients experienced a significant reduction in their pain levels. BioWorld MedTech Clinical Orthopedics Orthopedic implants Europe
Rising obesity levels spur endoscopic sleeve uptick

3 weeks ago | bioworld.com | Shani Alexander

Rising obesity levels spur endoscopic sleeve uptickWhile GLP-1 receptor agonists continue to grab the headlines as a treatment option for obesity, another therapy, endoscopic sleeve gastroplasty (ESG), is seeing a steady rise in demand. BioWorld MedTech Clinical Obesity Europe NICE
Abbott Tendyne TMVR secures FDA clearance

4 weeks ago | bioworld.com | Shani Alexander

Abbott Tendyne TMVR secures FDA clearanceAbbott Laboratories recently received FDA clearance for Tendyne, its transcatheter mitral valve replacement system. The news comes on the heels of Edwards Lifesciences Corp. securing a CE mark for its Sapien M3 system and is a boon for mitral valve therapies amid ongoing frustrations about the slow adoption of TMVR technologies. BioWorld MedTech Regulatory Cardiovascular Europe
FDA greenlights Distalmotion’s Dexter for gallbladder removal

1 month ago | bioworld.com | Shani Alexander

FDA greenlights Distalmotion’s Dexter for gallbladder removalThe U.S. FDA granted 510(k) clearance to Distalmotion SA's Dexter, its surgical robotic system, for use in cholecystectomy in adults. The greenlight from the regulatory body is the second nod Dexter has received following de novo clearance granted in 2024 for use in inguinal hernia repair. BioWorld MedTech Clinical Regulatory Robotic surgery U.S. FDA
Shockwave IVL system continues to make waves

1 month ago | bioworld.com | Shani Alexander

EuroPCR 2025Shockwave IVL system continues to make wavesShockwave Medical Inc. is confident that its intravascular lithotripsy (IVL) system can continue to dominate the market for calcium modification even as other technologies emerge, chief medical officer Nick West told BioWorld. BioWorld MedTech Cardiovascular Europe
Salvia raises $60M for neuromodulation migraine system

1 month ago | bioworld.com | Shani Alexander

Salvia raises $60M for neuromodulation migraine systemSalvia Bioelectronics BV raised $60 million in a series B financing round for its minimally invasive implantable neuromodulation device, Mysalvia therapy, which treats chronic migraine. The funds will be used for clinical trials and obtaining regulatory approvals in the U.S., Europe and Australia. BioWorld MedTech Financings Neurology/psychiatric Series B Europe
Edwards' data shows benefits of early intervention in aortic stenosis

1 month ago | bioworld.com | Shani Alexander

EuroPCR 2025Edwards' data shows benefits of early intervention in aortic stenosisEdwards Lifesciences Corp. released new economic and clinical data on severe aortic stenosis (AS) demonstrating intervening in a patient with the disease before symptoms develop can reduce costs to the health care system by $36,000. Data also shows earlier intervention can also lead to fewer follow-ups and hospitalizations for heart failure, after treatment. BioWorld MedTech Clinical EuroPCR Cardiovascular U.S.